Janssen COVID-19 Vaccine Recruiting Phase 3 Trials for Coronavirus Disease 2019 (COVID‑19) / Severe Acute Respiratory Syndrome (SARS) Prevention

IndicationsStatusPurposePhase
RecruitingPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT04838795Sisonke (Together): OPEN LABEL TRIAL COVID-19